Supplement on prostate cancer published by the Times. Click here to read
About Ipsen Limited
Ipsen Limited is the UK subsidiary of Ipsen, a global biopharmaceutical group with sales exceeding 1.1 billion euros in 2010, and total worldwide staff of more than 4,400.
